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ABSTRAK
Gigitan ular adalah masalah medis yang utama di India. Di antara berbagai manifestasinya, komplikasi 
serebral jarang ditemukan pada literatur. Terlebih lagi, stroke iskemik akibat gigitan ular cukup langka. Kami 
melaporkan serangkaian kasus dari dua kasus serupa yang mengembangkan manifestasi neurologis setelah 
gigitan ular viper Russell. Pada pemeriksaan CT scan menunjukkan infark serebral. Kemungkinan mekanisme 
penyebab kejadian yang mencakup koagulasi intravaskular diseminata, toksin yang diinduksi vaskulitis, dan 
kerusakan endotel akan dibahas pada artikel ini.
Kata kunci: strok iskemik, infark serebral, ular viper Russell, gigitan ular.
ABSTRACT
Snakebite is an important medical problem in India. Among their various manifestations, cerebral 
complications are uncommonly found in literature. Moreover, Ischemic stroke following snake bite is quite 
rare. Here we report a case series of two such cases that developed neurological manifestations following 
Russell’s viper bite. On computerized tomography (CT) scan of brain; cerebral infarcts were revealed. Their 
likely mechanisms are discussed in present study which include disseminated intravascular coagulation, toxin 
induced vasculitis and endothelial damage.
Keywords: ischemic stroke, cerebral infarct, Russell′s viper, snake bite.
INTRODUCTION
Over 20,00,000 cases of snake bites are 
reported annually in India, among them 35,000 
to 50,000 people die.1,2 Russell’s viper (Vipera 
russelli siamensis), is widely distributed and 
responsible for most of the fatalities of snake 
bite in India.2,3
Its envenoming causes multiple local and 
systemic manifestations including severe 
local bite site injury, cellulitis, neuroparalysis, 
coagulopathy, acute kidney injury (AKI), 
renal failure,  generalized rhabdomyolysis, 
shock, spontaneous systemic bleeding, and 
hemorrhagic manifestations including pituitary 
and intracranial hemorrhage.3 Very often, the 
neurological manifestations confine only to 
cranial nerves commonly causing ptosis and 
external ophthalmoplegia.
Only very few cases of ischemic stroke due 
to snake bites have been reported, suggesting 
the mechanisms such as toxic vasculitis causing 
endothelial injury leading to thrombosis, 
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hypotension and hypercoagulability state.4 
Here, we are presenting  two cases of an unusual 




A 70-year-old, previously healthy male was 
admitted in emergency department with a history 
of snake bite on right foot one day back, when 
he was walking in his garden. The offending 
snake was killed by his neighbors and later on 
identified as Russell’s viper. He presented with 
a history of bleeding gums, blackish colored 
urine, decreased urine output and swollen right 
foot. On examination, patient was conscious and 
coherent but bilateral ptosis was noted without 
any other focal neurological deficits and bleeding 
manifestations. His 20 minute whole blood clot 
test (20 WBCT) and urine albumin test  was 
positive with raised serum creatinine (2.5 mg/
dl). Patient was treated with 20 vials of anti-
snake venom (ASV) along with repeated doses 
of Neostigmine 0.5 mg I/M half hourly and 
atropine 0.6 mg I/V till ptosis was recovered. 
Antibiotic coverage along with Tetanus toxoid 
was also given. Patient was improving but on 
the 4th day, he had a seizure attack followed 
by involuntary movement of right upper limb 
along with decreased power of the right upper 
limb and lower limb for which he was treated 
with levetiracetam 500 mg tablet orally twice 
daily. His computerized tomogram (CT) scan 
of the brain was taken which revealed infarct in 
left capsuloganglionic area (Figure 1). Patient 
was treated with clopidogrel 75 mg per day 
orally. Power was improved and patient was later 
discharged on 12th day.
Case 2
A previously healthy male of 55 years 
was admitted for a snake bite on his left foot, 
sustained during working in his fields. The snake 
was later killed and identified as Russell’s viper. 
He presented with severe pain along with two 
deep fang marks, erythema and edema. There 
were no other hemorrhagic or neurological 
manifestations, but Twenty minute whole blood 
clotting test (20 minute WBCT) was positive. 
He was immediately treated with 30ml loading 
dose of equine polyvalent antisnake venom 
(ASV-ASIA, Bharat Serum and Vaccines 
Ltd.), followed by continuous intravenous 
administration of 30ml of anti-snake venom 
in normal saline. While receiving treatment, 
he developed ptosis, immediately 10 vials of 
ASV was given as infusion followed by again 
10 vials of ASV as infusion after 1 hour along 
with Neostigmine 0.5 mg I/M  half hourly and 
atropine 0.6 mg I/V till improvement. Tetanus 
toxoid was given and a course of antibiotic 
injection of Ceftriaxone was also started. On 
the next  day also further 5 vials of ASV was 
given as infusion along with tapering doses of 
atropine and neostigmine as 20 minute WBCT 
was still positive, which normalized on the 
3rd day. However, another dose of 10 vials of 
ASV was given on that day. Initial laboratory 
investigations revealed that blood sugar was 
100mg/dl, blood urea was 60 mg/dl, serum 
bilirubin was 2.3 mg/dl, serum creatinine was 1.6 
mg/dl, alanine transaminase was 38 IU, aspartate 
transaminase was 89 IU and alkaline phosphatase 
was 69IU/Lt.
On the seventh day, patient developed left 
side weakness and speech disturbances. Left 
hemiplegia and expressive aphasia was also 
revealed on neurological examination. Brain CT 
scan showed acute ischemic infarcts in bilateral 
frontal lobes. Lipid profile, Electrocardiogram, 
and Echocardiogram were normal. Patient was 
treated with asprin and clopidogrel orally.  There 
was remarkable improvement in the motor power 
and speech on discharge at the tenth day.
Figure 1. CT Brain showing acute infarcts in left 
capsuloganglionic area.
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DISCUSSION
This paper describes two cases of snake 
bite with an atypical clinical presentation. 
Cerebral complications, particularly ischemic 
complications, after snake bite are rare. Very 
few cases of cerebral infarction resulting from 
a viper bite have been reported.5-7 In a study 
including 309 snake bite patients, Mosquera, et 
al.5 reported cerebrovascular complications in 8 
patients (2.6%) only, 7 hemorrhagic strokes and 
1 ischemic stroke. Bashir and Jinkins reported 
a case in whom Russell’s viper envenomation 
resulted in hemiplegia and aphasia, consistent 
with bilateral frontal lobe infarction.6 similarly; 
Murthy, et al.7 reported a case of cerebral 
infarction and diffuse encephalopathy following 
a viper bite.
Viper snake venom is a complex toxin with 
rich components dominantly affecting hemostatic 
mechanisms.8 In large doses, it can cause massive 
intravascular coagulation leading to small and 
even large vessel occlusions resulting in cerebral 
infarction.9 Toxic vasculitis caused by certain 
viperine species may result in thrombosis.7 
Bashir and Jinkins6 suggested direct action 
of the venom on vascular endothelial cells. 
Hemorrhagins, the complement mediated, toxic 
components of Viperidae snake venom may 
result in severe vascular spasm, endothelial 
damage and increased vascular permeability all 
of which may contribute to vascular occlusion.7 
Hypercoagulation due to procoagulants in the 
venom, such as arginine, esterase and hydrolase6,7 
and hyperviscosity caused by hypovolemia and 
hypoperfusion secondary to hypotension may 
also contribute to vessel occlusion.
Our patient had both neurological (ptosis) 
and hematological manifestations (20MWBCT 
positive). Some of the Russell’s viper bite from 
south India has produced neuroparalysis with 
incoagulable blood.10 In India whole blood 
clotting time of more than 20 min is virtually 
diagnostic of viper bite and rules out elapid 
bite.10,11 Systemic spontaneous bleeding and 20 
minutes whole blood clotting test (20WBCT) are 
bedside tests to know systemic envenomation 
in viper bite. When there is no systemic 
envenomation the case should be observed for 
24 hrs clinically and with repeated 20WBCT 
before discharged.10,12
The patients developed cerebral infarction 
after 7 days, fairly similar to a report of an 
adolescent who developed bilateral posterior 
circulation stroke after 1 week of snake bite.13 
They concluded that stroke was probably due 
to toxic vasculitis or toxin-induced vascular 
spasm and endothelial damage.13 Ranawaka UK 
et al14 stated in their article that there was no 
agreed time cut-off for classifying neurological 
manifestations into ‘‘acute’’ and ‘‘delayed. 
Serum sickness type reactions develop in 1 
to 12 days after antivenom therapy (mean 7 
days). Clinical features include fever, nausea, 
arthralgia, myalgia, arthritis, mononeuritic 
multiplex, recurrent urticaria, lymphadenopathy, 
neuritis and even encephalopathy. They usually 
respond to oral antihistamine.10,11 but in our case, 
there were no such features and patient was 
improved with asprin and clopidogrel.
It seems that the cerebral infarction in our 
patients was the result of toxic vasculitis or toxin 
induced vascular spasm and endothelial damage 
as no other risk factors were present.
CONCLUSION
Following snake bite, emphasis should be 
given to the prompt diagnosis and treatment 
because the most important factor in determining 
survival following a severe envenomation is the 
amount of time elapsed between the bite and 
specific treatment. Early administration of ASV 
is essential to neutralize the maximum circulating 
venom before it is fixed in tissue. Therefore, 
it should be given to cases with evidence of 
systemic envenomation as early as possible.
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